PROFARMA (PFRM3) Main Indicators
Basic Data - PFRM3
| Company | PROFARMA |
| Corporate Name | PROFARMA DISTRIB PROD FARMACEUTICOS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Profarma atua na distribuição de produtos farmacêuticos. higiene pessoal e cosméticos. nos mais populosos estados brasileiros. |
| Share | PFRM3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 6.23 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 541.65 thousand |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 09/19/2024 | |
Relative Prices - PFRM3
| Price/Earnings | 8.52 |
| Price/SBV | 0.60 |
| Price/Net Sales | 0.09 |
| Price/CFO | 1.35 |
| Price/FCF | 1.58 |
| Price/Total Assets | 0.16 |
| Price/EBIT | 2.69 |
| Price/Working Capital | 0.72 |
| Price/NCAV | -0.30 |
| EV/EBIT | 5.40 |
| EV/EBITDA | 3.49 |
| EV/Net Sales | 0.17 |
| EV/CFO | 2.71 |
| EV/FCF | 3.18 |
| EV/Total Assets | 0.31 |
| Company Market Cap | R$ 771.35 M |
| Enterprise Value | R$ 1.55 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 6.23 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 6.19% |
| Updated 09/19/2024 | |
Income Statement - PFRM3
| Net Revenue | R$ 9.04 B |
| Gross Result | R$ 1.38 B |
| EBIT | R$ 286.49 M |
| Depreciation and Amortization | - R$ 157.71 M |
| EBITDA | R$ 444.21 M |
| Net Profit | R$ 90.58 M |
| Net Profit/Share | R$ 0.73 |
| Updated 08/07/2024 | |
| Net Revenue | R$ 2.28 B |
| Gross Result | R$ 386.49 M |
| EBIT | R$ 85.89 M |
| Depreciation and Amortization | - R$ 41.24 M |
| EBITDA | R$ 127.13 M |
| Net Profit | R$ 28.30 M |
| Profit/Share | R$ 0.23 |
| Updated 08/07/2024 | |
Price and Volume Behavior - PFRM3
| Lowest Price 52 weeks | R$ 3.23 |
| Highest Price 52 weeks | R$ 6.44 |
| Variation 2024 | 17.11% |
| Variation 1 year | 68.63% |
| Variation 2 years(total) | 81.52% |
| Variation 2 years(yearly) | 34.57% |
| Variation 3 years(total) | 32.80% |
| Variation 3 years(yearly) | 9.90% |
| Variation 4 years(total) | 53.83% |
| Variation 4 years(yearly) | 11.36% |
| Variation 5 years(total) | 84.59% |
| Variation 5 years(yearly) | 13.03% |
| Average Daily Volume (3 months) | R$ 1.12 M |
| Updated 09/19/2024 | |
Returns and Margins - PFRM3
| Return on Initial Tangible Capital | 8.86% |
| Return on Initial Invested Capital | 9.14% |
| Pre-Tax Return on Initial Tangible Capital | 13.43% |
| Pre-Tax Return on Initial Invested Capital | 13.85% |
| Return on Initial Shareholder´s Equity | 7.55% |
| Return on Initial Asset | 1.96% |
| Gross Margin | 15.28% |
| Net Margin | 1.00% |
| EBIT Margin | 3.17% |
| EBITDA Margin | 4.91% |
| Initial Asset Turnover | 1.96 |
| Financial Leverage | 3.83 |
| Liabilities/Net Worth | 2.83 |
| Net Debt/EBITDA | 1.75 |
| Updated 08/07/2024 | |
Balance Sheet - PFRM3
| Cash and Cash Equivalents | R$ 155.08 M |
| Total Assets | R$ 4.93 B |
| Short-Term Debt | R$ 400.05 M |
| Long-Term Debt | R$ 531.87 M |
| Gross Debt | R$ 931.92 M |
| Net Debt | R$ 776.84 M |
| Shareholder´s Equity | R$ 1.29 B |
| Share Book Value | R$ 10.41 |
| Common Shares | 123,813,000 |
| Preferred Shares | 0 |
| Total | 123,813,000 |
| Common Shares in Treasury | 1,202,000 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,202,000 |
| Common Shares (Except Treasury) | 122,611,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 122,611,000 |
| Updated 08/07/2024 | |
Cash Flow - PFRM3
| Operating Cash Flow | R$ 571.14 M |
| Cash Flow from Investments | - R$ 120.89 M |
| Financing Cash Flow | - R$ 451.38 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 1.14 M |
| Updated 08/07/2024 | |
| Operating Cash Flow | - R$ 42.10 M |
| Cash Flow from Investments | - R$ 32.47 M |
| Financing Cash Flow | - R$ 58.80 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 133.37 M |
| Updated 08/07/2024 | |
Experimental - PFRM3
| CAPEX 3 months | - R$ 21.59 M |
| Free Cash Flow 3 months | - R$ 63.69 M |
| CAPEX 12 months | - R$ 83.70 M |
| Free Cash Flow 12 months | R$ 487.44 M |
| Updated 08/07/2024 | |